Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China
Additional USD 250 million invested in advanced technical R&D and manufacturing facility opening in Changshu, furthering economic development of Jiangsu province and Suzhou city
04-Nov-2009 -
Novartis announced a USD 1 billion investment over the next five years, increasing R&D activities in China and confirming Novartis' long term commitment to China's further economic development, health reform and improving the health care of the Chinese people. The Novartis investment will include ...
active pharmaceutical ingredients
analytics
basic research
+14